Oregon Health and Science University
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Oregon Health and Science University sits in the top decile of US sponsors by registered trial count (#67 of 15,742 sponsors by registered trial count).
Oregon Health and Science University: 546 sponsored US clinical trials, 91 recruiting.
Oregon Health and Science University sponsors 546 registered US clinical trials on ClinicalTrials.gov, 91 of them currently recruiting, and 370 completed. 73 of these trials are in Phase 3-4 (later-stage) and 92 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 6 trials.
Top-decile sponsor footprint
Oregon Health and Science University ranks in the top decile of sponsors by registered trial count (#67 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
370 of 420 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
546 total, page 8 of 11
Effects of Monopolar Electrocautery Use During Surgery on Implanted Cardiac Defibrillators
NCT01572246
Using Optical Coherence Tomography to Capture Retinal Microvascular Changes Associated With Multiple Sclerosis
NCT01596881
Mindfulness Meditation Format Pilot Study
NCT01581983
The Effect of Nitroglycerin on the Intrauterine Device (IUD) Insertion Experience in Nulliparous Women
NCT01490073
Efficacy of Tart Cherry Juice in Reducing Muscle Injury and Biomarkers of Muscle Damage Among Healthy Adults
NCT01547949
Early Postpartum Intrauterine Device (IUD) Placement
NCT01594476
Relationship Between the Menstrual Cycle and Heart Disease in Women
NCT01546454
Conversations as a Means to Delay the Onset of Alzheimer's Disease
NCT01571427
Efficacy Study of Diabetes Group Visits
NCT01497301
Post Affordable Care Act Evaluation
NCT02657499
Pediatric Dysphagia Outcomes After Injection Laryngoplasty for Type I Laryngeal Cleft
NCT01507207
Abatacept in the Treatment of Uveitis
NCT01279954
CEI Van Outreach Screening Study
NCT01510392
The Effects of Work Schedule and Sleep Patterns on Caregivers' Health
NCT01443156
OCT-guided LALAK in Children
NCT01579643
OCT-guided DSAEK Graft Shaping and Smoothing
NCT01586234
Surgery Checklist and Process Improvement Surrounding Endoscopic Sinus Surgery
NCT01499719
The Effect of Donepezil on Gait and Balance in Parkinson's Disease
NCT01521117
Postural Instability in Progressive Supranuclear Palsy
NCT01563276
Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma Gait Parameters Study
NCT01565447
Dexmedetomidine on Intraoperative Somatosensory and Motor Evoked Potential Monitoring During Neurosurgery in Pediatric Patients
NCT01512147
Effects of a Longitudinal Health Literacy Training Program on Family Medicine Residents
NCT01474733
Spinal Cord Injury Leg Rehabilitation
NCT01498991
Use of a Training Video to Teach Medical Students About Health Literacy
NCT01460953
Refining Paracervical Block Techniques for Pain Control in First Trimester Surgical Abortion
NCT01466491
Evaluation of COMmunity of Practice And Safety Support (COMPASS) for Home Care Workers
NCT02113371
Tenaculum Pain Control Study
NCT01421641
Clinical Outcomes of Deep Brain Stimulator (DBS) Electrodes Placed Using Intraoperative Computed Tomography (CT) and Frameless Stereotaxis
NCT01703598
Study of Triheptanoin for Treatment of Long-Chain Fatty Acid Oxidation Disorder
NCT01379625
Corneal Opacities in Children
NCT02117323
Dalfampridine for Imbalance in Multiple Sclerosis
NCT01444300
SLOS: The Effect of Simvastatin in Patients Receiving Cholesterol Supplementation
NCT01434745
Trial of Continuous Versus Interrupted Feeding for Intubated Intensive Care Unit Patients
NCT01383980
Acupuncture and Nausea/Vomiting in Pediatric Patients
NCT01417741
Acupuncture for Sedation in the Intensive Care Unit (ICU)
NCT01362270
Costimulatory Molecules as Biomarkers in Cystic Fibrosis
NCT01353950
Contrast Ultrasound Perfusion Imaging in Peripheral Arterial Disease (PAD)
NCT01377649
Mindfulness Meditation in Chronic Stress
NCT01386060
Gait Parameters of Persons With Down Syndrome With and Without Orthotics Using GaitRite
NCT01390558
Balance and Mild Traumatic Brain Injury (TBI)
NCT01377454
Observational Study of Keratoconus and Post-keratoplasty Eyes
NCT02109848
Comparing Cetaphil Restoraderm System Versus Standard Skin Care in Infants
NCT01375205
Determinants of Medical and Surgical Treatment Outcomes in Chronic Sinusitis
NCT01332136
Evaluation of Safety and Health Involvement For Truck Drivers
NCT02105571
COPE-Co-morbidities, Parkinson's Disease and Exercise
NCT01361724
Determination of the Accuracy of a Non-Invasive Continuous Blood Pressure Device
NCT01311128
Microvascular and Cardiac Dysfunction in Paroxysmal Nocturnal Hemoglobinuria and Sickle Cell Disease
NCT01294891
The Effects of Emollient Therapy on the Skin Barrier
NCT01291940
Corneal Power, Astigmatism, and Aberration Changes After LASIK
NCT01893671
Cognitive Decline in Non-demented PD
NCT01340885
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 52 |
| Phase 2 | 40 |
| Phase 3 | 6 |
| Phase 4 | 67 |
Therapeutic Areas
What is open in the Oregon Health and Science University pipeline
91 recruiting of 546 indexed (17% open); 370 completed (68%).
Phase mix: 73 late (III/IV) vs 92 early (I/II) (balanced across stages).
Top condition: Obesity (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Oregon Health and Science University: open-pipeline peers nationwide
Peers matched on 546 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Oregon Health and Science University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 546 trials (± recruiting share)
- Ohio State University · 552 trials · 21% recruiting
- Amgen · 558 trials · 10% recruiting
- Merck Sharp & Dohme · 558 trials · 22% recruiting
- Virginia Commonwealth University · 558 trials · 14% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Adagene · 17% recruiting · 6 trials
- Agendia · 17% recruiting · 6 trials
- Akamis Bio · 17% recruiting · 6 trials
- Angiodynamics · 17% recruiting · 12 trials
Related
What to do with this Oregon Health and Science University page
546 registered trials is a research-attention snapshot, not an endorsement of Oregon Health and Science University or any single study.
- 91 of Oregon Health and Science University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Oregon Health and Science University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Oregon Health and Science University pipeline card: 546 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.